can diabetics take retatrutide RETATRUTIDE: A Medication for Diabetes and Weight Loss The Science Behind Retatrutide: A

Economic impacts of overweight and obesity: current and future estimates for 161 countries

For researchers who need pure GLP-1 agonism without confounding from GIP and glucagon pathways, semaglutide remains the better choice

This means retatrutide is currently only available for research purposes through specialized suppliers

If long-term side effects do occur, they are infrequent with proper monitoring

Phase 2 trial data showed that 12% of Retatrutide participants continued losing weight through week 48 without any plateau, while 8% reached their plateau before week 36 and then maintained successfully through the study end

Post-cycle therapy considerations arise when Testosterone use extends beyond temporary research periods